Poster Discussion
Lung cancer: therapeutic modalities, re-staging, and follow-up
Equal efficacy of gefitinib in chemonaive lung adenocarcinoma patients with either exon 19 deletion or L858R point mutation
C. Lin(Taipei, Taiwan)
COI
1
Lung adenocarcinoma mimicking interstitial lung disease showed good response to navelbine monotherapy
Y. Park(Daejeon, Republic of Korea)
COI
2
Pemetrexed in maintenance therapy of 164 patients with advanced non-small-cell lung cancer (NSCLC)
J. Skřičková(Brno 35, Czech Republic)
COI
3
Impact of second-line treatment on overall survival of advanced lung adenocarcinoma patients
C. Chai(Petaling Jaya (Selangor), Malaysia)
COI
4
Chemotherapy toxicity in advanced non-small cell lung cancer and its impact on survival
H. Cherif(Tunis, Tunisia)
COI
5
Risk factors of febrile neutropenia induced by chemotherapy in lung cancer patients
S. Tsuchida(Miyazaki-shi, Japan)
COI
6
Does consolidation chemotherapy improves survival for locally advanced non-small-cell lung cancer patients receiving concurrent chemoradiotherapy?
B. Kömürcüoğlu(Izmir, Turkey)
COI
7
Checkpointinhibition in lung cancer – How to distinguish pseudoprogression from progressive disease
A. Rittmeyer(Immenhausen, Germany)
COI
8
Progression vs. pseudo progression in the treatment of squamous NSCLC with nivolumab
S. Rüdiger(Ulm, Germany)
COI
9
What predicts radiation pneumonitis best? Pulmonary injury after curatively intended radiotherapy of early-stage lung cancer
J. Berg(Porsgrunn, Norway)
COI
10
Early surgical resection for stage I high-grade neuroendocrine caricinoma of lung
E. Mochizuki(Shizuoka, Japan)
COI
11
Management of residual pleural space and persistent airleak after major lung resection
K. Athanassiadi(Athens, Greece)
COI
12
Should preoperative FDG uptake on PET/CT guide postoperative surveillance in surgical non-small cell lung cancer (NSCLC)
E. Denneny(London, United Kingdom)
COI
13
Evaluation of response to chemotherapy with fiberoptic bronchoscopy in lung cancers
K. Jandric(Banja Luka, Bosnia and Herzegovina)
COI
14
Lung cancer revisited – CT scan and bronchoscopy concordance after treatment
C. Vaz Guerreiro(Faro, Portugal)
COI
15
Screening for intracerebral metastasis in radically treated non-small cell lung cancer patients
W. Lim(Leeds (West Yorkshire), United Kingdom)
COI
16
A case with a primary adrenal insufficiency secondary to nivolumab
T. Göksel(Izmir, Turkey)
COI
17
LATE-BREAKING ABSTRACT: Early relapse of non-small cell lung cancer (NSCLC) found after CNS-symptoms
N. Hansen(Odense C, Denmark)
COI
18
. . .